IBDEI117 ; ; 09-AUG-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,1679,0)
 ;;=OBSESSIVE-COMPULSIVE & RELATED DISORDERS^19^114
 ;;^UTILITY(U,$J,358.4,1680,0)
 ;;=PERSONAL HX & CURRENT CIRCUMSTANCES^22^114
 ;;^UTILITY(U,$J,358.4,1681,0)
 ;;=COUNSELING/MEDICAL ADVICE^5^114
 ;;^UTILITY(U,$J,358.4,1682,0)
 ;;=SOCIAL ENVIRONMENT PROBLEMS^29^114
 ;;^UTILITY(U,$J,358.4,1683,0)
 ;;=PARAPHILIC DISORDERS^21^114
 ;;^UTILITY(U,$J,358.4,1684,0)
 ;;=PERSONALITY DISORDERS^23^114
 ;;^UTILITY(U,$J,358.4,1685,0)
 ;;=CRIME/LEGAL SYSTEM PROBLEMS^6^114
 ;;^UTILITY(U,$J,358.4,1686,0)
 ;;=PSYCHOSOCIAL/PERSONAL/ENVIRONMENTAL^24^114
 ;;^UTILITY(U,$J,358.4,1687,0)
 ;;=RELATIONAL PROBLEMS^25^114
 ;;^UTILITY(U,$J,358.4,1688,0)
 ;;=SCHIZOPHRENIA/OTH PSYCHOTIC DISORDERS^26^114
 ;;^UTILITY(U,$J,358.4,1689,0)
 ;;=SEXUAL DYSFUNCTIONS^27^114
 ;;^UTILITY(U,$J,358.4,1690,0)
 ;;=SLEEP-WAKE DISORDERS^28^114
 ;;^UTILITY(U,$J,358.4,1691,0)
 ;;=SUBSTANCE USE DISORDER-ALCOHOL^31^114
 ;;^UTILITY(U,$J,358.4,1692,0)
 ;;=SUBSTANCE USE DISORDER-CANNABIS^33^114
 ;;^UTILITY(U,$J,358.4,1693,0)
 ;;=SUBSTANCE USE DISORDER-HALLUCINOGEN^34^114
 ;;^UTILITY(U,$J,358.4,1694,0)
 ;;=SUBSTANCE USE DISORDER-OPIOID^36^114
 ;;^UTILITY(U,$J,358.4,1695,0)
 ;;=SUBSTANCE USE DISORDER-SEDATIVE/HYPNOTIC^37^114
 ;;^UTILITY(U,$J,358.4,1696,0)
 ;;=SUBSTANCE USE DISORDER-TOBACCO^39^114
 ;;^UTILITY(U,$J,358.4,1697,0)
 ;;=TRAUMA/STRESSOR-RELATED DISORDERS^42^114
 ;;^UTILITY(U,$J,358.4,1698,0)
 ;;=SUBSTANCE USE DISORDER-INHALANT^35^114
 ;;^UTILITY(U,$J,358.4,1699,0)
 ;;=CLINICAL RESEARCH PROGRAM^4^114
 ;;^UTILITY(U,$J,358.4,1700,0)
 ;;=SOMATIC SYMPTOM & RELATED DISORDERS^30^114
 ;;^UTILITY(U,$J,358.4,1701,0)
 ;;=DISRUPTIVE,IMPULSE-CONTROL DISORDERS^8^114
 ;;^UTILITY(U,$J,358.4,1702,0)
 ;;=ELIMINATION DISORDERS^11^114
 ;;^UTILITY(U,$J,358.4,1703,0)
 ;;=GAMBLING DISORDER^13^114
 ;;^UTILITY(U,$J,358.4,1704,0)
 ;;=OTHER MENTAL DISORDERS^20^114
 ;;^UTILITY(U,$J,358.4,1705,0)
 ;;=NEURODEVELOPMENTAL DISORDERS^18^114
 ;;^UTILITY(U,$J,358.4,1706,0)
 ;;=SUBSTANCE USE DISORDER-CAFFEINE^32^114
 ;;^UTILITY(U,$J,358.4,1707,0)
 ;;=SUICIDAL IDEATIONS^41^114
 ;;^UTILITY(U,$J,358.4,1708,0)
 ;;=SUBSTANCE USE DISORDER-UNKNOWN SUBSTANCE^40^114
 ;;^UTILITY(U,$J,358.4,1709,0)
 ;;=SUBSTANCE USE DISORDER-STIMULANTS^38^114
 ;;^UTILITY(U,$J,358.4,1710,0)
 ;;=UNDERDOSING OF MEDICATION REGIMEN^43^114
 ;;^UTILITY(U,$J,358.4,1711,0)
 ;;=OTHER^7^115
 ;;^UTILITY(U,$J,358.4,1712,0)
 ;;=CASE MANAGEMENT SERVICES^1^115
 ;;^UTILITY(U,$J,358.4,1713,0)
 ;;=HOME HEALTH VISIT^5^115
 ;;^UTILITY(U,$J,358.4,1714,0)
 ;;=COMMUNITY RESIDENTIAL CARE^2^115
 ;;^UTILITY(U,$J,358.4,1715,0)
 ;;=SMOKING/TOBACCO USE CESSATION^8^115
 ;;^UTILITY(U,$J,358.4,1716,0)
 ;;=HEALTH AND BEHAVIOR ASSESSMENT^4^115
 ;;^UTILITY(U,$J,358.4,1717,0)
 ;;=EDUCATION/TRAINING^3^115
 ;;^UTILITY(U,$J,358.4,1718,0)
 ;;=ADMINISTRATIVE PURPOSES^1^116
 ;;^UTILITY(U,$J,358.4,1719,0)
 ;;=CONDITIONS INFLUENCING HEALTH^2^116
 ;;^UTILITY(U,$J,358.4,1720,0)
 ;;=FAMILY CIRCUMSTANCES^4^116
 ;;^UTILITY(U,$J,358.4,1721,0)
 ;;=HOUSING/ECONOMIC CIRCUMSTANCES^5^116
 ;;^UTILITY(U,$J,358.4,1722,0)
 ;;=MENTAL/BEHAVIORAL PROBLEMS^9^116
 ;;^UTILITY(U,$J,358.4,1723,0)
 ;;=ORGAN/TISSUE REPLACED^11^116
 ;;^UTILITY(U,$J,358.4,1724,0)
 ;;=POSTPROCEDURAL STATES^15^116
 ;;^UTILITY(U,$J,358.4,1725,0)
 ;;=PSYCHOSOCIAL CIRCUMSTANCES^16^116
 ;;^UTILITY(U,$J,358.4,1726,0)
 ;;=PERSONAL HX OF HAZARDS TO HEALTH^12^116
 ;;^UTILITY(U,$J,358.4,1727,0)
 ;;=PERSONS SEEKING CONSULT^14^116
 ;;^UTILITY(U,$J,358.4,1728,0)
 ;;=LIFESTYLE PROBLEMS^6^116
 ;;^UTILITY(U,$J,358.4,1729,0)
 ;;=MENTAL/DEVELOPMENTAL SCRN^10^116
 ;;^UTILITY(U,$J,358.4,1730,0)
 ;;=PERSONAL HX OF MENTAL DISORDER^13^116
 ;;^UTILITY(U,$J,358.4,1731,0)
 ;;=SENSES/FUNCTION PROBLEMS^17^116
 ;;^UTILITY(U,$J,358.4,1732,0)
 ;;=MACHINE/DEVICE DEPENDENCE^8^116
 ;;^UTILITY(U,$J,358.4,1733,0)
 ;;=UPPER LIMB AMPUTATION STATUS^19^116
 ;;^UTILITY(U,$J,358.4,1734,0)
 ;;=LOWER LIMB AMPUTATION STATUS^7^116
 ;;^UTILITY(U,$J,358.4,1735,0)
 ;;=UNAVAILABILITY OF MED FACILITY CARE^18^116
 ;;^UTILITY(U,$J,358.4,1736,0)
 ;;=CONVALENSCENCE/PALLIATIVE CARE^3^116
 ;;^UTILITY(U,$J,358.4,1737,0)
 ;;=NEW PATIENT^2^117
 ;;^UTILITY(U,$J,358.4,1738,0)
 ;;=ESTABLISHED PATIENT^1^117
 ;;^UTILITY(U,$J,358.4,1739,0)
 ;;=CONSULTATIONS^3^117
 ;;^UTILITY(U,$J,358.4,1740,0)
 ;;=TELEHEALTH FACILITY FEE^1^118
 ;;^UTILITY(U,$J,358.4,1741,0)
 ;;=A DIAGNOSES^1^119
 ;;^UTILITY(U,$J,358.4,1742,0)
 ;;=D DIAGNOSES^4^119
 ;;^UTILITY(U,$J,358.4,1743,0)
 ;;=E DIAGNOSES^5^119
 ;;^UTILITY(U,$J,358.4,1744,0)
 ;;=F DIAGNOSES^6^119
 ;;^UTILITY(U,$J,358.4,1745,0)
 ;;=I DIAGNOSES^9^119
 ;;^UTILITY(U,$J,358.4,1746,0)
 ;;=K DIAGNOSES^10^119
 ;;^UTILITY(U,$J,358.4,1747,0)
 ;;=M DIAGNOSES^12^119
 ;;^UTILITY(U,$J,358.4,1748,0)
 ;;=N DIAGNOSES^13^119
 ;;^UTILITY(U,$J,358.4,1749,0)
 ;;=P DIAGNOSES^15^119
 ;;^UTILITY(U,$J,358.4,1750,0)
 ;;=R DIAGNOSES^16^119
 ;;^UTILITY(U,$J,358.4,1751,0)
 ;;=S DIAGNOSES^17^119
 ;;^UTILITY(U,$J,358.4,1752,0)
 ;;=T DIAGNOSES^18^119
 ;;^UTILITY(U,$J,358.4,1753,0)
 ;;=V DIAGNOSES^20^119
 ;;^UTILITY(U,$J,358.4,1754,0)
 ;;=X DIAGNOSES^22^119
 ;;^UTILITY(U,$J,358.4,1755,0)
 ;;=C DIAGNOSES^3^119
 ;;^UTILITY(U,$J,358.4,1756,0)
 ;;=W DIAGNOSES^21^119
 ;;^UTILITY(U,$J,358.4,1757,0)
 ;;=B DIAGNOSES^2^119
 ;;^UTILITY(U,$J,358.4,1758,0)
 ;;=G DIAGNOSES^7^119
 ;;^UTILITY(U,$J,358.4,1759,0)
 ;;=H DIAGNOSES^8^119
 ;;^UTILITY(U,$J,358.4,1760,0)
 ;;=L DIAGNOSES^11^119
 ;;^UTILITY(U,$J,358.4,1761,0)
 ;;=O DIAGNOSES^14^119
 ;;^UTILITY(U,$J,358.4,1762,0)
 ;;=U DIAGNOSES^19^119
 ;;^UTILITY(U,$J,358.4,1763,0)
 ;;=Z DIAGNOSES^23^119
 ;;^UTILITY(U,$J,358.4,1764,0)
 ;;=TELERETINAL PROCEDURES^1^120
 ;;^UTILITY(U,$J,358.4,1765,0)
 ;;=LOW VISION / OTHER^19^121
 ;;^UTILITY(U,$J,358.4,1766,0)
 ;;=RETINA - DM / VASCULAR^12^121
 ;;^UTILITY(U,$J,358.4,1767,0)
 ;;=EYELIDS / LASHES^2^121
 ;;^UTILITY(U,$J,358.4,1768,0)
 ;;=NEURO / STRABISMUS^16^121
 ;;^UTILITY(U,$J,358.4,1769,0)
 ;;=ORBIT - PLASTICS^18^121
 ;;^UTILITY(U,$J,358.4,1770,0)
 ;;=VITREOUS^15^121
 ;;^UTILITY(U,$J,358.4,1771,0)
 ;;=ORBIT - TRAUMA^17^121
 ;;^UTILITY(U,$J,358.4,1772,0)
 ;;=LACRIMAL / NLD / NEOPLASMS^3^121
 ;;^UTILITY(U,$J,358.4,1773,0)
 ;;=MOST FREQUENT / TOP 30^1^121
 ;;^UTILITY(U,$J,358.4,1774,0)
 ;;=CONJUNTIVA / SCLERA^4^121
 ;;^UTILITY(U,$J,358.4,1775,0)
 ;;=CORNEA / ULCER^5^121
 ;;^UTILITY(U,$J,358.4,1776,0)
 ;;=LENS / CATARACT / POSTOP^6^121
 ;;^UTILITY(U,$J,358.4,1777,0)
 ;;=IRIS / UVEITIS^7^121
 ;;^UTILITY(U,$J,358.4,1778,0)
 ;;=GLAUCOMA - OPEN ANGLE^8^121
 ;;^UTILITY(U,$J,358.4,1779,0)
 ;;=GLAUCOMA - CLOSED ANGLE^9^121
 ;;^UTILITY(U,$J,358.4,1780,0)
 ;;=GLAUCOMA - SECONDARY^10^121
 ;;^UTILITY(U,$J,358.4,1781,0)
 ;;=RETINA - CHOROID / TUMORS / INFLAM^13^121
 ;;^UTILITY(U,$J,358.4,1782,0)
 ;;=RETINA - TEAR / PERIPH / DEGENERATION^14^121
 ;;^UTILITY(U,$J,358.4,1783,0)
 ;;=RETINA - MACULA^11^121
 ;;^UTILITY(U,$J,358.4,1784,0)
 ;;=NEW PATIENT^2^122
 ;;^UTILITY(U,$J,358.4,1785,0)
 ;;=ESTABLISHED PATIENT^1^122
 ;;^UTILITY(U,$J,358.4,1786,0)
 ;;=CONSULTATIONS^3^122
 ;;^UTILITY(U,$J,358.4,1787,0)
 ;;=POST OP VISIT (GLOBAL)^4^122
 ;;^UTILITY(U,$J,358.4,1788,0)
 ;;=BONE MARROW^1^123
 ;;^UTILITY(U,$J,358.4,1789,0)
 ;;=HEART^2^123
 ;;^UTILITY(U,$J,358.4,1790,0)
 ;;=HEART-LUNG^3^123
 ;;^UTILITY(U,$J,358.4,1791,0)
 ;;=LIVER^4^123
 ;;^UTILITY(U,$J,358.4,1792,0)
 ;;=LUNG^5^123
 ;;^UTILITY(U,$J,358.4,1793,0)
 ;;=PANCREAS^6^123
 ;;^UTILITY(U,$J,358.4,1794,0)
 ;;=RENAL^8^123
 ;;^UTILITY(U,$J,358.4,1795,0)
 ;;=REPAIR/RESECTION OF DONOR HEART^9^123
 ;;^UTILITY(U,$J,358.4,1796,0)
 ;;=PROLONGED SERVICE^7^123
 ;;^UTILITY(U,$J,358.4,1797,0)
 ;;=CHRONIC PULM. HEART DISEASE^1^124
 ;;^UTILITY(U,$J,358.4,1798,0)
 ;;=DIS. OF BLOOD/FORMING ORGA^3^124
 ;;^UTILITY(U,$J,358.4,1799,0)
 ;;=HERNIA^5^124
 ;;^UTILITY(U,$J,358.4,1800,0)
 ;;=KIDNEY/PANCREAS^6^124
 ;;^UTILITY(U,$J,358.4,1801,0)
 ;;=LIVER^7^124
 ;;^UTILITY(U,$J,358.4,1802,0)
 ;;=LUNG^8^124
 ;;^UTILITY(U,$J,358.4,1803,0)
 ;;=MALIGNANT LYMPH & HEMATOP^9^124
 ;;^UTILITY(U,$J,358.4,1804,0)
 ;;=MALIGNANT NEOPLASMS SOLID ORGANS^10^124
 ;;^UTILITY(U,$J,358.4,1805,0)
 ;;=METABOLIC DISORDERS^11^124
 ;;^UTILITY(U,$J,358.4,1806,0)
 ;;=SYMPTOMS/SIGNS^12^124
 ;;^UTILITY(U,$J,358.4,1807,0)
 ;;=COMPLICATIONS OF SURGERY^2^124
 ;;^UTILITY(U,$J,358.4,1808,0)
 ;;=DONORS OF ORGANS AND TISSUES^4^124
 ;;^UTILITY(U,$J,358.4,1809,0)
 ;;=NEW PATIENT^2^125
 ;;^UTILITY(U,$J,358.4,1810,0)
 ;;=ESTABLISHED PATIENT^1^125
 ;;^UTILITY(U,$J,358.4,1811,0)
 ;;=POST-OP (GLOBAL)^3^125
 ;;^UTILITY(U,$J,358.4,1812,0)
 ;;=JOINT INJECTIONS^15^126
 ;;^UTILITY(U,$J,358.4,1813,0)
 ;;=TENDON INJECTION^26^126
 ;;^UTILITY(U,$J,358.4,1814,0)
 ;;=SKIN PROCEDURES^24^126
 ;;^UTILITY(U,$J,358.4,1815,0)
 ;;=ADMINISTRATION OF INJ MEDICATIONS^2^126
 ;;^UTILITY(U,$J,358.4,1816,0)
 ;;=EKG^11^126
 ;;^UTILITY(U,$J,358.4,1817,0)
 ;;=NOSEBLEEDS^16^126
 ;;^UTILITY(U,$J,358.4,1818,0)
 ;;=REMOVAL FB IN EAR^18^126
 ;;^UTILITY(U,$J,358.4,1819,0)
 ;;=INJECTABLE MEDICATIONS^14^126
 ;;^UTILITY(U,$J,358.4,1820,0)
 ;;=INFUSION MEDICATIONS^12^126
 ;;^UTILITY(U,$J,358.4,1821,0)
 ;;=ADMINISTRATION OF IV MEDICATIONS^3^126
 ;;^UTILITY(U,$J,358.4,1822,0)
 ;;=INHALATION SOLUTIONS THRU DME^13^126
 ;;^UTILITY(U,$J,358.4,1823,0)
 ;;=ADMINISTRATION OF DME^1^126
 ;;^UTILITY(U,$J,358.4,1824,0)
 ;;=DEMO OF METERED INHALER^10^126
 ;;^UTILITY(U,$J,358.4,1825,0)
 ;;=BLOOD TESTS^7^126
 ;;^UTILITY(U,$J,358.4,1826,0)
 ;;=BLOOD PRESSURE MEASURE^6^126
 ;;^UTILITY(U,$J,358.4,1827,0)
 ;;=BLADDER ^5^126
 ;;^UTILITY(U,$J,358.4,1828,0)
 ;;=BLOOD TRANSFUSION^8^126
 ;;^UTILITY(U,$J,358.4,1829,0)
 ;;=AIRWAY TREATMENTS^4^126
 ;;^UTILITY(U,$J,358.4,1830,0)
 ;;=BURN TREATMENT^9^126
 ;;^UTILITY(U,$J,358.4,1831,0)
 ;;=TB TEST^25^126
 ;;^UTILITY(U,$J,358.4,1832,0)
 ;;=REPAIR-SIMPLE-SCALP,NK,TRUNK^20^126
 ;;^UTILITY(U,$J,358.4,1833,0)
 ;;=REPAIR-SIMPLE-FACE,MUCOUS^19^126
 ;;^UTILITY(U,$J,358.4,1834,0)
 ;;=REPAIR-INTERM-SCALP,TRUNK^23^126
